Business Wire

The Open Group OSDU™ Forum Launches the OSDU Data Platform Mercury Release

24.3.2021 12:00:00 EET | Business Wire | Press release

Share

The Open Group, the vendor-neutral technology consortium, today announced the OSDU Data Platform Mercury Release. Developed by The Open Group OSDU™ Forum, the OSDU Data Platform is an Open Source, standards-based and technology-agnostic data platform for the energy industry that stimulates innovation, industrializes data management, and reduces time to market for new solutions.

The OSDU Data Platform will provide over time access to a vast portfolio of open and proven vendor-developed applications from a broad range of energy sources. By accessing this ecosystem, developers no longer have to develop and maintain the monolithic architecture needed to deliver unique value-add services. Now, with a single set of well-defined and industry-specific APIs, organizations can easily accelerate platform design and develop proprietary applications on top of the OSDU Data Platform.

With an Open Source approach, any company – from established corporations to start-up challenger companies – can contribute new features to the platform, supporting a variety of business workflows. All work is validated by the OSDU Program Management Committee (PMC) to ensure it is aligned with the overall direction of the Forum.

With a single view of industry data, the OSDU Data Platform can be harnessed for innovative business applications. The Mercury Release of the OSDU Data Platform is now available to Operators and Software Developers who want to:

  • Liberate data from traditional silos and make all data discoverable and usable in a single data platform
  • Enable new integrated exploration and development workflows that reduce overall cycle time
  • Take advantage of emerging digital solutions to provide scalability and accelerate decision making

Steve Nunn, President and CEO of The Open Group, commented: “The OSDU Data Platform Mercury Release represents an important achievement by the OSDU Forum in a very short space of time. Established in 2018, the OSDU Forum has accumulated over 185 Member organizations who are collaborating together to accelerate innovation and reduce costs in the energy sector. With a standard data platform, energy companies will be able to drive innovation by integrating digital technologies and utilizing open standards for better decision making. Looking ahead, this will be imperative to meet the world’s increasing energy demands while reducing greenhouse gas emissions.”

Johan Krebbers, GM Emerging Digital Technologies / VP IT Innovation, Shell, commented: “At the heart of most energy companies’ strategies is embracing the transformational technologies taking us forward in today’s digital era. This makes the need for a common architectural design clear, one that underpins how our industry works with its data.”

David Eyton, EVP Innovation & Engineering, bp, commented: “Data is at the heart of bp’s transformation into an integrated energy company. We believe that the future of the energy industry will be data driven and dependent on its ability to manage data in a manner that promotes data sharing with partners, innovation through data science, and rapid decision making throughout the lifecycle of the energy value chains. Being a founding member of the OSDU Forum, bp has had an opportunity to be part of an organization that is fundamentally changing the data landscape for our industry. By integrating energy organizations, cloud services providers, and software vendors, the OSDU Forum is providing an opportunity for collaboration that will be beneficial for all involved. We are very excited about the Mercury Release of the OSDU Data Platform and look forward to expanding this approach into engineering, emissions, and new energy.”

To learn more about how to develop applications the OSDU Data Platform, visit the application developer community page here.

The current OSDU Forum Member List is available here.

-ENDS-

About The Open Group OSDU Forum

The Open Group OSDUTM Forum enables the Energy industry to develop transformational technology to support the world’s changing Energy needs. The OSDU Forum is available to all energy stakeholders including application developers, service operators, technology providers, software companies, academia, and more. More information on the OSDU Forum can be found here.

About The Open Group

The Open Group is a global consortium that enables the achievement of business objectives through technology standards. Our diverse membership of more than 800 organizations includes customers, systems and solutions suppliers, tool vendors, integrators, academics, and consultants across multiple industries. For more information, visit www.opengroup.org.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Contact:
Jenny Morris
Hotwire
+44 (0)7393465529
UKOpengroup@hotwirepr.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye